Start date: 01 August 2020
End date: 31 July 2024
The overall aim of MAD-CoV 2 project is to develop and deliver a treatment for COVID-19 patients, which will significantly increase our capacity to handle the current outbreak of SARS-CoV-2. In addition, we will identify and characterize new targets for the development of antiviral therapeutics by using state-of-the-art technology
Scientific coordinator of the project: Ali Mirazimi